SMTL ID : 3zrc.2 (3 other biounits)

pVHL54-213-EloB-EloC complex (4R)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-N-[4-(1,3-OXAZOL-5-YL)BENZYL]-L-PROLINAMIDE bound

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x L8B: (4R)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-N-[4-(1,3-OXAZOL-5-YL)BENZYL]-L-PROLINAMIDE(Non-covalent)

L8B.1: 11 residues within 4Å: Chain C: W.38, F.41, Y.48, P.49, L.51, I.59, H.60, S.61, Y.62, H.65, W.67 10 PLIP interactions: 10 interactions with chain C Hydrophobic interactions: C:W.38, C:Y.48, C:Y.48, C:I.59, C:I.59, C:Y.62, C:W.67 Hydrogen bonds: C:H.60, C:Y.62, C:H.65

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Buckley, D.L. et al., Targeting the Von Hippel-Lindau E3 Ubiquitin Ligase Using Small Molecules to Disrupt the Vhl/Hif-1Alpha Interaction. J.Am.Chem.Soc. (2012)

Release Date

2012-03-07

Peptides

TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2: A
TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1: B
VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

B
E

C
F

TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2

TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1

VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR

Related Entries With Identical Sequence